[HTML][HTML] DNA methylation as a biomarker for monitoring disease outcome in patients with hypovitaminosis and Neurological Disorders
O Martínez-Iglesias, V Naidoo, L Corzo, R Pego… - Genes, 2023 - mdpi.com
DNA methylation remains an under-recognized diagnostic biomarker for several diseases,
including neurodegenerative disorders. In this study, we examined differences in global …
including neurodegenerative disorders. In this study, we examined differences in global …
DNA Methylation as a Biomarker for Monitoring Disease Outcome in Patients with Hypovitaminosis and Neurological Disorders.
O Martínez-Iglesias, V Naidoo, L Corzo, R Pego… - Genes, 2023 - europepmc.org
DNA methylation remains an under-recognized diagnostic biomarker for several diseases,
including neurodegenerative disorders. In this study, we examined differences in global …
including neurodegenerative disorders. In this study, we examined differences in global …
[PDF][PDF] DNA Methylation as a Biomarker for Monitoring Disease Outcome in Patients with Hypovitaminosis and Neurological Disorders. Genes 2023, 14, 365
O Martínez-Iglesias, V Naidoo, L Corzo, R Pego… - 2023 - researchgate.net
DNA methylation remains an under-recognized diagnostic biomarker for several diseases,
including neurodegenerative disorders. In this study, we examined differences in global …
including neurodegenerative disorders. In this study, we examined differences in global …
DNA Methylation as a Biomarker for Monitoring Disease Outcome in Patients with Hypovitaminosis and Neurological Disorders
O Martínez-Iglesias, V Naidoo, L Corzo, R Pego… - Genes, 2023 - agris.fao.org
DNA methylation remains an under-recognized diagnostic biomarker for several diseases,
including neurodegenerative disorders. In this study, we examined differences in global …
including neurodegenerative disorders. In this study, we examined differences in global …
DNA Methylation as a Biomarker for Monitoring Disease Outcome in Patients with Hypovitaminosis and Neurological Disorders
O Martínez-Iglesias, V Naidoo, L Corzo, R Pego… - Genes, 2023 - search.proquest.com
DNA methylation remains an under-recognized diagnostic biomarker for several diseases,
including neurodegenerative disorders. In this study, we examined differences in global …
including neurodegenerative disorders. In this study, we examined differences in global …
[HTML][HTML] DNA Methylation as a Biomarker for Monitoring Disease Outcome in Patients with Hypovitaminosis and Neurological Disorders
O Martínez-Iglesias, V Naidoo, L Corzo, R Pego… - Genes, 2023 - ncbi.nlm.nih.gov
DNA methylation remains an under-recognized diagnostic biomarker for several diseases,
including neurodegenerative disorders. In this study, we examined differences in global …
including neurodegenerative disorders. In this study, we examined differences in global …
DNA Methylation as a Biomarker for Monitoring Disease Outcome in Patients with Hypovitaminosis and Neurological Disorders
O Martínez-Iglesias, V Naidoo, L Corzo, R Pego… - …, 2023 - pubmed.ncbi.nlm.nih.gov
DNA methylation remains an under-recognized diagnostic biomarker for several diseases,
including neurodegenerative disorders. In this study, we examined differences in global …
including neurodegenerative disorders. In this study, we examined differences in global …
[PDF][PDF] DNA Methylation as a Biomarker for Monitoring Disease Outcome in Patients with Hypovitaminosis and Neurological Disorders. Genes 2023, 14, 365
O Martínez-Iglesias, V Naidoo, L Corzo, R Pego… - 2023 - pdfs.semanticscholar.org
DNA methylation remains an under-recognized diagnostic biomarker for several diseases,
including neurodegenerative disorders. In this study, we examined differences in global …
including neurodegenerative disorders. In this study, we examined differences in global …
DNA Methylation as a Biomarker for Monitoring Disease Outcome in Patients with Hypovitaminosis and Neurological Disorders.
O Martínez-Iglesias, V Naidoo, L Corzo, R Pego… - …, 2023 - search.ebscohost.com
DNA methylation remains an under-recognized diagnostic biomarker for several diseases,
including neurodegenerative disorders. In this study, we examined differences in global …
including neurodegenerative disorders. In this study, we examined differences in global …